Logo of Dorsavi (ASX:DVL)Latest Dorsavi (ASX:DVL) News

Page 5
Page 5 of 6

dorsaVi Advances RRAM to 22 nm Node, Targeting Faster, Denser Memory

dorsaVi has launched an evaluation program to scale its oxide-based RRAM technology from 40 nm to 22 nm, aiming for significant gains in density, speed, and energy efficiency. This move could enhance its wearable sensor devices and embedded AI applications.
Sophie Babbage
6 Nov 2025

dorsaVi Accelerates RRAM Innovation with New CEO and US Market Breakthrough

dorsaVi reports breakthrough RRAM sensor performance and secures a major US physical therapy deal, backed by a $5 million capital raise and new leadership appointments.
Victor Sage
28 Oct 2025

dorsaVi’s ViMove+ Surges with 15x Growth in US Physical Therapy Market

dorsaVi reports a striking 15-fold increase in US Physical Therapy clinic subscriptions for its ViMove+ product, driven by strong surgeon endorsements and a successful face-to-face training rollout.
Ada Torres
7 Oct 2025

dorsaVi Validates RRAM Reflex Platform with Sub-Microsecond Speed and Nanojoule Efficiency

dorsaVi has confirmed its RRAM Reflex Platform achieves biological-grade reflexes with sub-microsecond latency and ultra-low energy use, outperforming leading digital edge AI systems by orders of magnitude.
Sophie Babbage
1 Oct 2025

dorsaVi Validates Sub-Millisecond RRAM Reflex Platform for Robotics and Prosthetics

dorsaVi has achieved a major engineering milestone by validating its RRAM-powered Reflex Platform, delivering neural reflex decisions in under one microsecond with ultra-low energy consumption. This breakthrough paves the way for next-generation robotics, prosthetics, and wearable devices that require rapid, energy-efficient reflex actions.
Sophie Babbage
17 Sept 2025

dorsaVi Secures Five-Year Deal to Expand US Physical Therapy Reach

dorsaVi has inked a five-year sales agreement with Select Medical, opening access to over 1,900 US outpatient physical therapy centers for its FDA-approved motion analysis products. This follows a successful 18-month pilot validating clinical benefits in athlete rehabilitation.
Ada Torres
10 Sept 2025

DorsaVi Navigates Revenue Dip Amid Strategic Capital Boost

DorsaVi Limited reported a 13.9% revenue decline and a 21.7% rise in net loss for FY25, while securing over $3 million in capital to fuel new technology ventures.
Victor Sage
29 Aug 2025

dorsaVi Taps Mathew Regan to Drive AI and Robotics Breakthroughs

dorsaVi appoints Mathew Regan as Group CEO to spearhead commercialisation of next-gen RRAM-enabled AI and robotics technologies, aiming for global expansion.
Sophie Babbage
28 Aug 2025

dorsaVi Launches Artemis Labs to Pioneer AI and Robotics with Next-Gen RRAM

dorsaVi Ltd has unveiled Artemis Labs, a new subsidiary focused on developing advanced AI, sensor, and robotics technologies powered by cutting-edge RRAM. This initiative aims to transform human movement data into intelligent robotic and healthcare applications.
Sophie Babbage
20 Aug 2025

dorsaVi Secures $5M to Propel RRAM Sensor and Robotics Innovation

dorsaVi Ltd has raised A$5 million through a strategic placement to accelerate development of its next-generation RRAM-enabled sensors and robotics platforms, signaling a bold expansion into edge AI and neuromorphic computing.
Sophie Babbage
18 Aug 2025

dorsaVi Advances Robotics with Ultra-Low Latency RRAM Reflex Platform

dorsaVi Ltd is expanding its RRAM technology evaluation to next-generation robotics, aiming to deliver sub-millisecond reflexes that could revolutionize safety and dexterity in collaborative robots and wearables.
Sophie Babbage
4 Aug 2025

dorsaVi Secures Exclusive RRAM License, Boosts Sensor Tech and US Expansion

dorsaVi has acquired exclusive global rights to advanced RRAM technology, promising major performance gains in its biomedical sensors, while securing key contracts and raising $2.44 million to fuel US market growth.
Victor Sage
30 July 2025